Induced Biological Response in Contact with Ag-and Cu-Doped Carbon Coatings for Potential Orthopedic Applications

Silver and copper as additives of various biomaterials have been reported as the potential solutions for biomedicine applications, mostly because of inducing bactericidal effects. The application of those admixtures in diamond-like carbon (DLC) coatings may be desirable for orthopedic implants. In the present manuscript, the biological effect of coatings with up to about 7 at.% and 14 at.% of, respectively, Cu and Ag is compared. The morphology, chemical structure, and composition of films deposited on AISI 316LVM and Ti6Al7Nb is characterized. The live/dead analysis conducted with Escherichia coli shows a higher bactericidal potential of silver than copper. Although the Cu-doped coatings can positively affect the proliferation of Saos-2 and EA.hy926 cell lines, the results of XTT test are on the verge of 70% of viability. Biological effect of silver on EA.hy926 cell lines is negative but that admixture ensures high proliferation of osteoblasts in contact with coatings deposited on titanium alloy (over 20% better than for substrate material). In that case, the viability is reaching about 85% for Ag-doped coatings on AISI 316LVM and 75% on Ti6Al7Nb. The results indicate that for the sake of bactericidal coatings that may promote osteointegration, the candidates are DLC with silver content no higher than 10 at.%.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

Materials (Basel, Switzerland) - 14(2021), 8 vom: 09. Apr.

Sprache:

Englisch

Beteiligte Personen:

Jastrzębski, Krzysztof [VerfasserIn]
Białecki, Jerzy [VerfasserIn]
Jastrzębska, Aleksandra [VerfasserIn]
Kaczmarek, Anna [VerfasserIn]
Para, Marcin [VerfasserIn]
Niedzielski, Piotr [VerfasserIn]
Bociaga, Dorota [VerfasserIn]

Links:

Volltext

Themen:

Bactericidal effect
Copper admixture
DLC
EA.hy926
Journal Article
Saos-2
Silver admixture

Anmerkungen:

Date Revised 02.05.2021

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/ma14081861

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM324718322